Combination of HLA-DRB1 alleles as a factor causing risks of sporadic congenital heart defects and congenital malformations without chromosome diseases

View or download the full article: 
PDF icon health-risk-analysis-2021-1-14.pdf
UDC: 
612.17
DOI: 
10.21668/health.risk/2021.1.14.eng
Authors: 

A.V. Shabaldin1,2, A.V. Tsepokina1, O.V. Dolgikh3, E.V. Shabaldina2, A.V. Ponasenko1

Organization: 

1Scientific Research Institute for Complex Issues of Cardiovascular Diseases, 6 Sosnovyi Blvd., Kemerovo, 650002, Russian Federation
2Kemerovo State Medical University, 22a Voroshilova Str., Kemerovo, 650056, Russian Federation
3Federal Scientific Center for Medical and Preventive Health Risk Management Technologies, 82 Monastyrskaya Str., Perm, 614045, Russian Federation

Abstract: 

Congenital heart defects are anomalies that are becoming more and more frequent every year. Their specific weight is the highest among all the defects and malformations in fetus. Besides, children with sporadic congenital heart defects and malformations are still born rather frequently. We made an assumption that congenital heart defects (CHD) and congenital malformations (CM) were formed due to inflammatory process decompensation within «mother – fetus» system occurring in case of a conflict as per HLA between a semi-allogenic fetus and its mother’s microenvironment. A risk of such a conflict might be associated with certain HLA combinations in parents’ genotypes.
Our research goal was to reveal peculiarities of HLA-DRB1 alleles combinations in married couples who had children with sporadic CHD and CM without any chromosome diseases and to determine whether such peculiarities could cause risks of congenital anomalies.
We determined frequency of 14 alleles in HLA-DRB1 gene in all people who took part in the research.
Our research allowed establishing that parents whose children suffered from CHD more frequently had common HLA-DRB104, female HLA-DRB107 with male HLA-DRB113, HLA-DRB117 and female HLA-DRB113 with male HLA-DRB114. Children who suffered from CM more frequently had parents who were homologous as per HLA-DRB112, as well as with female HLA-DRB112 and male HLA-DRB101, HLA-DRB104, HLA-DRB113, and HLA-DRB115; this greater frequency was statistically significant. We also detected an authentic increase in frequency of HLA-DRB112 allele in children against their parents. Children with CM also had HLA-DRB112 allele statistically significantly more frequently than healthy children.
Peculiarities related to HLA-DRB1 alleles combination are genetic predictors of CHD and CM occurrence; their determination will allow minimizing risks of such disorders due to early diagnostics and timely prevention.

Keywords: 
major histocompatibility complex, HLA-DRB1, alleles, congenital heart diseases, congenital malformations, risk factor, married couples, spouse compatibility
Shabaldin A.V., Tsepokina A.V., Dolgikh O.V., Shabaldina E.V., Ponasenko A.V. Combination of hla-drb1 alleles as a factor causing risks of sporadic congenital heart defects and congenital malformations without chromosome diseases. Health Risk Analysis, 2021, no. 1, pp. 133–142. DOI: 10.21668/health.risk/2021.1.14.eng
References: 
  1. Petersdorf E.W., O'hUigin C. The MHC in the era of next-generation sequencing: Implications for bridging structure with function. Human immunology, 2019, vol. 80, no. 1, pp. 67–78. DOI: 10.1016/j.humimm.2018.10.002
  2. Chen N., Wang W., Wang F., Dong L., Zhao S., Zhang W., Zhu F. The distributions of HLA‐A, HLA‐B, HLA‐C, HLA‐DRB1 and HLA‐DQB1 allele and haplotype at high‐resolution level in Zhejiang Han population of China. International journal of immunogenetics, 2019, vol. 46, no. 1, pp. 7–16. DOI: 10.1111/iji.12411
  3. Vojvodić S.I., Ademović-Sazdanić D.S. Distribution of HLA DRB1, DQA1 and DQB1 Allelic Main Groups in the Vojvodina Province of Serbia: Genetic Relatedness with Other Populations. Russian Journal of Genetics, 2019, vol. 55, no. 1, pp. 124–130. DOI: 10.1111/j.1744-313X.2012.01122.x
  4. Zhang X., Cheng Y., Zhang Q., Wang X., Lin Y., Yang C., Fan X. [et al.]. Meta-Analysis Identifies Major Histocompatiblity Complex Loci in or Near HLA-DRB1, HLA-DQA1, HLA-C as Associated with Leprosy in Chinese Han Population. Meta-Analysis, 2019, vol. 139, no. 4, pp. 957–960. DOI: 10.1016/j.jid.2018.09.029
  5. Kiseleva A.N., Butina E.V., Isaeva N.V., Zaitseva G.A., Pozdeev N.M., Ovchinnikov V.V. Distribution of antigens of the HLA-system in married couples with reproductive disorders. Obstetrics, Gynecology and Reproduction, 2019, vol. 13, no. 2, pp. 111–118. DOI: 10.17749/2313-7347.2019.13.2.111-118
  6. Tashiro R., Niizuma K., Khor S.S., Tokunaga K., Fujimura M., Sakata H., Tominaga T. Identification of HLA-DRB1*04: 10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: A case-control study. PloS One, 2019, vol. 14, no. 8, pp. e0220858. DOI: 0.1371/journal.pone.0220858
  7. Makarchenko O.S., Gordeeva L.A., Shabaldin A.V., Glushkova O.A., Shatalina I.V., Simonova T.A., Filipenko M.L., Glushkov A.N., Kryukov P.M. Genes' immune presentation and immunoregulations role in forming conditions for fetus's losses. Mat' i ditya v Kuzbasse, 2008, no. 3 (34), pp. 13–20 (in Russian).
  8. Lopes S.A.V.D.A., Guimarães I.C.B., Costa S.F.D.O., Acosta A.X., Sandes K.A., Mendes C.M.C. Mortality for critical congenital heart diseases and associated risk factors in newborns. A cohort study. Arquivos brasileiros de cardiologia, 2018, vol. 111, no. 5, pp. 666–673. DOI: 10.5935/abc.20180203
  9. Kafian A.S., Mirshahi A., Amouzeshi A., Ramazani A.A., Bahman B., Hasanzadeh T.M., Salehi F. Epidemiologic Study of Congenital Heart Diseases and Its Related Factors in Children Referred to the Pediatric Cardiac Clinic of Birjand University of Medical Sciences, Iran. International Journal of Pediatrics, 2019, vol. 7, no. 12, pp. 10455–10463. DOI: 10.22038/ijp.2019.41467.3497
  10. Aimagambetova G., Hajjej A., Malalla Z.H., Finan R.R., Sarray S., Almawi W.Y. Maternal HLA‐DR, HLA‐DQ, and HLA‐DP loci are linked with altered risk of recurrent pregnancy loss in Lebanese women: A case‐control study. American Journal of Reproductive Immunology, 2019, vol. 82, no. 4, pp. e13173. DOI: 10.1111/aji.13173
  11. Emmery J., Hachmon R., Pyo C.W., Nelson W.C., Geraghty D.E., Andersen A.M.N., Hviid T.V.F. Maternal and fetal human leukocyte antigen class Ia and II alleles in severe preeclampsia and eclampsia. Genes & Immunity, 2016, vol. 17, no. 4, pp. 251–260. DOI: 10.1038/gene.2016.20
  12. Grimstad F., Krieg S. Immunogenetic contributions to recurrent pregnancy loss. Journal of assisted reproduction and genetics, 2016, vol. 33, no. 7, pp. 833–847. DOI: 10.1007/s10815-016-0720-6
  13. Guseva V., Lapin S., Myachikova V., Maslyanski A., Chuchlovin A., Ivanova N., Tkachenko O., Blinova T., Totolian A. Clinical importance of determination of hla-drb1 locus genes in rheumatoid arthritis. Medical Immunology (Russia), 2019, vol. 21, no. 2, pp. 333–340. DOI: 10.15789/1563-0625-2019-2-333-340
  14. Bland J.M., Altman D.G. The odds ratio. BMJ, 2016, vol. 320, no. 7247, pp. 1468. DOI: 10.1136/bmj.320.7247.1468
  15. Nunes M.E.G., Rosa D.V., Fagundes E.D.T., Ferreira A.R., Miranda D.M.D., Ferri Liu P.M. HLA-DRB1 gene polymorphisms in pediatric patients with type 1 autoimmune hepatitis and type 1 autoimmune hepatitis overlap syndrome with autoimmune cholangitis. Arquivos de gastroenterologia, 2019, vol. 56, no. 2, pp. 146–150. DOI: 10.1590/S0004-2803.201900000-29
  16. Tashiro R., Niizuma K., Khor S.S., Tokunaga K., Fujimura M., Sakata H., Tominaga T. Identification of HLA-DRB1*04: 10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: A case-control study. PloS One, 2019, vol. 14, no. 8, pp. e0220858. DOI: 10.1371/journal.pone.0220858
  17. Yu D., Feng Y., Yang L., Da M., Fan C., Wang S., Mo X. Maternal Socioeconomic Status and the Risk of Congenital Heart Defects in Offspring: A Meta-Analysis of 33 Studies. PLoS ONE, 2014, vol. 9, no. 10, pp. e111056. DOI: 10.1371/journal.pone.0111056
  18. Korochkin L.I. Ontogenez, evolyutsiya i geny [Ontogenesis, evolution, and genes]. Priroda, 2002, no. 7, pp. 63–77 (in Russian).
  19. Chuyanova A.A., Tsepokina A.V., Shabaldin A.V., Litvinova N.A., Zubrikova K.Yu., Boldyreva M.N. Features olfactory screening for HLA-DRB1 among unrelated donors of different sex. Immunologiya, 2015, vol. 36, no. 2, pp. 90–95 (in Russian).
  20. Kular L., Liu Y., Ruhrmann S., Zheleznyakova G., Marabita F., Gomez-Cabrero D., Aeinehband S. [et al.]. DNA methylation as a mediator of HLA-DRB1*15: 01 and a protective variant in multiple sclerosis. Nature communications, 2018, vol. 9, no. 1, pp. 1–15. DOI: 10.1038/s41467-018-04732-5
  21. Eltayeb‐Elsheikh N., Khalil E., Mubasher M., Al Jurayyan A., AlHarthi H., Omer W.H., Elghazali G. Association of HLA‐DR‐DQ alleles, haplotypes, and diplotypes with Type 1 diabetes in Saudis. Diabetes/Metabolism Research and Reviews, 2020, pp. e3345. DOI: 10.1002/dmrr.3345
  22. Erlebacher A. Immunology of the maternal-fetal interface. Annu Rev Immunol, 2013, vol. 31, pp. 387–411. DOI: 10.1146/annurev-immunol-032712-100003
  23. Kovalic A.J., Bonkovsky H.L. The Pathogenesis of Autoimmune Liver Diseases. In Diagnosis and Management of Autoimmune Hepatitis, 2020, pp. 9–50.
  24. Eidan A.J., AL-Harmoosh R.A., Hadi Z.J. Association of HLA-DRB1 Alleles with Allergic Asthma and Total Serum IgE Levels in Iraqi Adults Patients. Indian Journal of Public Health Research & Development, 2020, vol. 10, no. 1, pp. 505–510. DOI: 10.5958/0976-5506.2019.00099.8
Received: 
26.09.2020
Accepted: 
03.03.2021
Published: 
30.03.2021

You are here

Home